Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Swiss pharmaceutical firm Novartis AG plans to invest $23 billion in the US over the next five years to ensure its key drugs ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pharmaceutical company Novartis said it plans to expand U.S.-based manufacturing and research and development, with a total investment of $23 billion over the next five years. The company said it ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

The Swiss pharmaceutical company Novartis has announced significant investments in the US, days after President Donald Trump threatened to impose tariffs on foreign drugs. The company announced ...

It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.

With the new facilities, Novartis will be able to produce 100% of the key medicines sold in the US entirely in the US, the pharmaceutical company announced in the US on Friday night. It said this ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...